David Strupp Discusses Rodman and Renshaw One Of The Largest Investment Conferences Worldwide
Considered to be bankers for the growth industry, Rodman and Renshaw goes beyond the life science industries.
Blog
Wound Management Proves Strong Potential With Distribution Agreements In Place
OneMedRadio interviewed President and Director Deborah Jenkins Hutchinson and got a glimpse into this emerging growth company.
Verisante Technologies Detects Skin Cancer in Less Than A Second
OneMedRadio interviewed Thomas Braun, CEO of Verisante Technologies [CVE:VRS], a medical device company committed to commercializing innovative systems for the early detection of cancer.
Financings and business developments in the global diagnostics business
Biocept, Inc., a privately-held CLIA-certified laboratory testing company, and Clarient, Inc. (a GE Healthcare Company) say that they will be collaborating on the commercialization of a proprietary blood test for circulating tumor cells…
Sept 11-13, 2011 Rodman & Renshaw Global Healthcare Conference
Rodman & Renshaw holds its 13th annual Global Investment Health care Conference this September at the Waldorf=Astoria in New York.
Wound Management Technologies Inks Distribution Deal Worth Initial $2M
Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, recently announced a major distribution deal with Marketing Media Enterprises.
ThermoGenesis Sees Explosive Growth Opportunities in Stem Cells
Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.
September 26-28 AdvaMed 2011
Kenneth Mendez discusses this year’s MedTech Conference for CEOs, business executives, policy makers, financiers, media, and industry stakeholders from around the world.
International Stem Cell Corp Develops Similar Embryonic Stem Cells Without Fertilized Embryos
Ken Aldrich, Executive Chairman of International Stem Cell [OTC:ISCO] was interviewed by OneMedRadio where he discussed the company’s regenerative medicine therapies.
Vasomedical Announces Agreement to Acquire Two China-Based Companies
Further Implements Global Growth Strategy and Strengthens Manufacturing, Distribution and Technology Base